Survival with bladder cancer, evaluation of delay in treatment, type of surgeon, and modality of treatment

British Medical Journal

Volumn 303, Issue 6800, 1991, Pages 437-440

  Gulliford, M C ^a   Petruckevitch, A ^a   Burney, P G J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CONTROLLED STUDY; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOTHERAPY; SURVIVAL RATE; UNITED KINGDOM;

EID: 0025769656     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.303.6800.437     Document Type: Article

References (22)

1. Charlton, J.R.H.; RMi, Hartley; Silver, R.; Holland WW'. Geographical variation in mortality from conditions amenable to medical intervention in England and Wales I.ancet 1983 i: 691
2. Buck, N.; l)evlin HB; Lunon, J.N. The report of a confidential enquiry into perisperative deaths 1987
3. Raghavan, D.; Shipley, W.U.; Garnick, M.B.; Russell, P.J.; Richie, J.P. Biology and management of bladder cancer N Engl_7,]ed 1990 322 1129
4. Trunkey, D. Report to the Council of the Association of Surgeons of Great Britain and Ireland 1989 299 31
5. Mould, R.F. Cancer treatment services (radiotherapy) in London Lancet 1986 i: 1385
6. Dixon, W.J. BMDP statistical software manual 2 1990 759
7. Aso, Y.; Andersen, L.; Soloway, M.; Bosuffioux, C.; Chisholm, G.; Debryne, F. Prognostic factors in superficial bladder cancer Prog Clin Biol Res 1986 162 257
8. Richards, B.; Aso, Y.; Bollack, C.; Fossa, S.; Koontz, W.; Matsuda, M. Prognostic factors in infiltrating bladder cancer Prog Clin Biol Res 1986 162 27
9. Mameghan, H.; Fisher, R. Invasive bladder cancer: prognostic factors and results of radiotherapy with and without cystectomy Br] Urrol 1989 10.1111/j.1464-410X.1989.tb05185.x 63 251
10. Abel, P.D. P'rognostic indices in transitional cell carcinoma of the bladder 1988 62 103
11. Gtlllford, M.C.; IPetruckevitch, A.; Burney, P.G.J. Hospital case notes and medical audit: evaluation of non-response 1991 302 1128
12. Mommsen, S.; Aagaard, J.; Sell, A. Presenting symptoms, treatment delay and sur-vival in bladder cancer Scand] Urol Nephrol 1983 10.3109/00365598309180162 17 163
13. Bishop, M.C. I'he dangers of a long urological waiting list Br J Urol 1990 10.1111/j.1464-410X.1990.tb14781.x 65 433
14. Soloway, M.S. Selecting initial therapy for bladder cancer Cancer 1987 10.1002/1097-0142(19870801)60:3+<502::AID-CNCR2820601512>3.0.CO;2-W 60 502
15. Hope-Stone, H.F.; Oliver, R.T.D.; England, H.R.; Blandy, J.P. T3 bladder cancer: salvage rather than elective cystectommy after radiotherapy Urology 1984 10.1016/0090-4295(84)90199-7 24 315
16. Shearer, R.J.; Chilvers, C.E.D.; Bloom, H.J.G.; Bliss, J.M.; Horwich, A.; Babiker, A. Adjuvant chemotherapy in T3 carcinoma of the bladder; a prospective trial. A preliminary report Brj Urol 1988 10.1111/j.1464-410X.1988.tb04426.x 62 558
17. Dubois, R.W.; Brook, R.H.; Rogers, W.H. Adjusted hospital death rates: a potential screen for quality Am,7 Public Health 1987 10.2105/AJPH.77.9.1162 77 1162
18. Green, J.; Wintfeld, N.; Sharkey, P.; Passman, L.J. The importance of severity of illness in assessing hospital mortality JAMA 1990 10.1001/jama.1990.03440020075036 263 241
19. Park, R.E.; Brook, R.H.; Kosecoff, J.; Keesey, J.; Rubenstein, L.; Keeler, E. Explaining sariations in hospital death rates: randomness, severity of illness, quality of care JAMA 1990 10.1001/jama.1990.03450040080035 264 484
20. Dubois, R.W.; Rogers, W.H.; NMoxley, J.H.; D)raper, D.; Brook, R.H. Hospital inpatient mortality: is it a predictor of quality N Engl J Med 1987 10.1056/NEJM198712243172626 317 1674
21. Hopkins, A. Aleasuring the qualirt of medical care 1990
22. Tonkin, K.; Tannock, I. Evaluation of response and morbidity following treatment of bladder cancer 1988 228 The management ofbladder cancer